1. Concomitant febuxostat enhances methotrexate-induced hepatotoxicity by inhibiting breast cancer resistance protein
   Kenji Ikemura et al, 2019, Scientific Reports CrossRef
2. The current treatment strategy for gouty arthritis
   M. S. Petrova et al, 2018, Modern Rheumatology Journal CrossRef
3. Determination of febuxostat in human plasma by high performance liquid chromatography (HPLC) with fluorescence-detection
   Bishoy Kamel et al, 2019, Journal of Chromatography B CrossRef
4. A pharmacokinetic‐pharmacodynamic study of a single dose of febuxostat in healthy subjects
   Bishoy Kamel et al, 2020, British Journal of Clinical Pharmacology CrossRef
5. Clinical Pharmacokinetics and Pharmacodynamics of Febuxostat
   Bishoy Kamel et al, 2017, Clinical Pharmacokinetics CrossRef
6. Previous Dosage of Allopurinol Is a Strong Determinant of Febuxostat Efficacy
   Hiroyoshi Koide et al, 2017, Biological & Pharmaceutical Bulletin CrossRef
7. Population pharmacokinetic analysis of febuxostat with high focus on absorption kinetics and food effect
   Wenjun Chen et al, 2024, BMC Pharmacology and Toxicology CrossRef
8. Higher Febuxostat Exposure Observed in Asian Compared with Caucasian Subjects Independent of Bodyweight
   Dinko Rekić et al, 2021, Clinical Pharmacokinetics CrossRef
9. Simulation of febuxostat pharmacokinetics in healthy subjects and patients with impaired kidney function using physiologically based pharmacokinetic modeling
   Yichao Xu et al, 2022, Biopharmaceutics & Drug Disposition CrossRef
10. Population pharmacokinetic modelling of febuxostat in healthy subjects and people with gout
    Bishoy Kamel et al, 2022, British Journal of Clinical Pharmacology CrossRef
11. An integrated population pharmacokinetic model of febuxostat in pediatric patients with hyperuricemia including gout and adult population of healthy subjects and patients with renal dysfunction
    Ryutaro Iwama et al, 2024, Pharmacology Research & Perspectives CrossRef
12. Febuxostat for the chronic management of hyperuricemia in patients with gout
    Sandra Pamela Chinchilla et al, 2016, Expert Review of Clinical Pharmacology CrossRef
13. A sensitive HPLC-FL method to simultaneously determine febuxostat and diclofenac in rat plasma: assessment of metabolic drug interactions in vitro and in vivo
    Dong-Gyun Han et al, 2020, Analytical Methods CrossRef
14. Side Effects and Interactions of the Xanthine Oxidase Inhibitor Febuxostat
    Andreas Jordan et al, 2018, Pharmaceuticals CrossRef